Analyst picks & changes

Agouron Pharmaceuticals Inc.

(AGPH), La Jolla, Calif.

Business: Infectious diseases/AIDS

Montgomery Securities analyst David Crossen said that data on AGPH's

Viracept

protease inhibitor in triple combination therapy with

AZT

and

3TC

was comparable to

Read the full 379 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE